Daniela Fenoglio et al.
Human vaccines & immunotherapeutics, 11(4), 838-850 (2015-02-26)
Peptide540-548, peptide611-626, peptide672-686 and peptide766-780, which are derived from human telomerase, constitute the immunogenic component of the GX301 cancer vaccine. The relative immunogenicity of these peptides is unknown, thus it is unsure whether their combined use offers real advantages over